Mithra Pharmaceuticals SA announced that it will receive 3,871,500 shares at a price of €6.07 per share for gross proceeds of €23,500,000 on June 21, 2022. The transaction will include participation from professional, institutional and private investors, including Leon Van Rompaey, Chief Executive Officer for 3,900,000 shares. Issue price of €6.07 per share, representing a 5% discount to closing share price.

The company will issue equity in the transaction. The transaction is expected to be completed on or about June 24, 2022.